This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2002 Jun 4;105(22):2580-2.

doi: 10.1161/01.cir.0000020353.63751.2f.

Patent foramen ovale and recurrent stroke: another paradoxical twist

Jonathan L Halperin, Valentin Fuster

PMID: 12045158
DOI: 10.1161/01.cir.0000020353.63751.2f

Editorial

Patent foramen ovale and recurrent stroke: another paradoxical twist

Jonathan L Halperin et al. Circulation. 2002.

. 2002 Jun 4;105(22):2580-2.

doi: 10.1161/01.cir.0000020353.63751.2f.

Authors

Jonathan L Halperin, Valentin Fuster

PMID: 12045158
DOI: 10.1161/01.cir.0000020353.63751.2f

No abstract available

PubMed Disclaimer

Comment on

Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study.
Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP; PFO in Cryptogenic Stroke Study (PICSS) Investigators. Homma S, et al. Circulation. 2002 Jun 4;105(22):2625-31. doi: 10.1161/01.cir.0000017498.88393.44. Circulation. 2002. PMID: 12045168 Clinical Trial.

Similar articles

Patent foramen ovale and recurrent stroke: closure is the best option: yes.
Furlan AJ. Furlan AJ. Stroke. 2004 Mar;35(3):803-4. doi: 10.1161/01.STR.0000117963.58978.40. Epub 2004 Feb 12. Stroke. 2004. PMID: 14963269 No abstract available.
Patent foramen ovale and cryptogenic stroke. A critical review.
Ballerini L, Cifarelli A, Ammirati A, Gimigliano F. Ballerini L, et al. J Cardiovasc Med (Hagerstown). 2007 Jan;8(1):34-8. doi: 10.2459/01.JCM.0000247433.82322.df. J Cardiovasc Med (Hagerstown). 2007. PMID: 17255814 Review.
Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S, Furlan AJ, Reisman M, Burke D, Vardi M, Wimmer NJ, Ling S, Chen X, Kent DM, Massaro J, Mauri L; CLOSURE I Investigators. Elmariah S, et al. JACC Cardiovasc Interv. 2014 Aug;7(8):913-20. doi: 10.1016/j.jcin.2014.01.170. JACC Cardiovasc Interv. 2014. PMID: 25147037 Clinical Trial.
Transcatheter closure of patent foramen ovale in patients with paradoxical embolism: intermediate-term risk of recurrent neurological events.
Du ZD, Cao QL, Joseph A, Koenig P, Heischmidt M, Waight DJ, Rhodes J, Brorson J, Hijazi ZM. Du ZD, et al. Catheter Cardiovasc Interv. 2002 Feb;55(2):189-94. doi: 10.1002/ccd.10067. Catheter Cardiovasc Interv. 2002. PMID: 11835645
[Cryptogenic stroke and patent foramen ovale].
Windecker S, Nedeltchev K, Wahl A, Meier B. Windecker S, et al. Ther Umsch. 2003 Sep;60(9):553-61. doi: 10.1024/0040-5930.60.9.553. Ther Umsch. 2003. PMID: 14579624 Review. German.

See all similar articles

Cited by

Transthoracic contrast echocardiography using vitamin B6 and sodium bicarbonate as contrast agents for the diagnosis of patent foramen ovale.
He JC, Zheng JY, Li X, Yang Y, Zhang BY, Chen Y, Li XF, Liu YM, Cao Y, Zhao L, Li TC. He JC, et al. Int J Cardiovasc Imaging. 2017 Aug;33(8):1125-1131. doi: 10.1007/s10554-017-1088-0. Epub 2017 Feb 7. Int J Cardiovasc Imaging. 2017. PMID: 28176181
Long-term follow-up after percutaneous closure of patent foramen ovale with Amplatzer PFO Occluder: a single center experience.
Araszkiewicz A, Grygier M, Iwańczyk S, Trojnarska O, Lesiak M, Grajek S. Araszkiewicz A, et al. Postepy Kardiol Interwencyjnej. 2016;12(1):49-54. doi: 10.5114/pwki.2016.56949. Epub 2016 Feb 11. Postepy Kardiol Interwencyjnej. 2016. PMID: 26966449 Free PMC article.
"Migraine side effect" and stroke recurrence in late follow-up after transcatheter patent foramen ovale closure as secondary prevention of cryptogenic thromboembolism.
Kumor M, Biernacka EK, Demkow M, Konka M, Płatek AE, Jagodzińska M, Hoffman P. Kumor M, et al. Postepy Kardiol Interwencyjnej. 2014;10(3):155-60. doi: 10.5114/pwki.2014.45141. Epub 2014 Sep 11. Postepy Kardiol Interwencyjnej. 2014. PMID: 25489300 Free PMC article.
Hypoxemia from right-to-left shunting through a patent foramen ovale in right ventricular infarction: treatment by revascularization, preload reduction, and, finally, interventional PFO closure.
Kuch B, Riehle M, von Scheidt W. Kuch B, et al. Clin Res Cardiol. 2006 Dec;95(12):680-4. doi: 10.1007/s00392-006-0442-3. Epub 2006 Sep 28. Clin Res Cardiol. 2006. PMID: 16998741 No abstract available.
Antithrombotic therapy for stroke in young adults.
Payne JR, Coull B. Payne JR, et al. J Thromb Thrombolysis. 2005 Oct;20(2):127-32. doi: 10.1007/s11239-005-3206-4. J Thromb Thrombolysis. 2005. PMID: 16205861 Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information